| FMCCX | VEMPX | FMCCX / VEMPX | |
| Total Expense Ratio | 0.68 | 0.04 | 1,700% |
| Annual Report Gross Expense Ratio | 0.68 | 0.04 | 1,700% |
| Fund Existence | 30 years | 15 years | - |
| Gain YTD | 4.778 | 5.786 | 83% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.16B | 83.9B | 3% |
| Annual Yield % from dividends | 0.48 | 1.10 | 43% |
| Returns for 1 year | -0.77 | 2.67 | -29% |
| Returns for 3 years | 21.95 | 45.41 | 48% |
| Returns for 5 years | 23.13 | 36.40 | 64% |
| Returns for 10 years | 47.12 | 140.37 | 34% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DTCAX | 20.51 | 0.08 | +0.39% |
| BNY Mellon Sust US Equity A | |||
| UOPSX | 93.08 | N/A | N/A |
| ProFunds UltraNASDAQ-100 Svc | |||
| MSVDX | 6.33 | N/A | N/A |
| Morgan Stanley Vitality Portfolio I | |||
| CBGAX | 15.01 | N/A | N/A |
| ClearBridge Global Infrastructure Inc C | |||
| JFNIX | 81.94 | -0.17 | -0.21% |
| Janus Henderson Global Life Sciences I | |||